Suzanne B. Merrill, MD

4.8 out of 5 from 305 Patient Satisfaction Ratings. Learn more about the survey.
Suzanne B. Merrill, MD
Urologic Oncology, Urology

Academic Appointments

Associate Program Director, Urology Residency Program
Associate Professor of Surgery

Call for an appointment

Are you a physician or provider?

Refer a Patient

About Me

Suzanne B. Merrill, MD, is currently an Assistant Professor of Surgery and Urologic Oncologist in the Division of Urology at the Penn State Milton S. Hershey Medical Center in Hershey, PA. She graduated summa cum laude from The University of Delaware where she received a bachelor of arts with honors in biology and chemistry. She attended The University of North Carolina Chapel Hill School of Medicine where she graduated with AOA honors. Dr. Merrill completed her urology residency at Duke University followed by a urologic oncology fellowship at The Mayo Clinic in Rochester, Minnesota.  While at Mayo she also received a certificate in translational research science.

Dr. Merrill's clinical practice focuses on treatment of all primary or recurrent urologic cancers. She has the ability to utilize the techniques of either open or laparoscopic/robotic-assisted surgery to provide more individualized care to her patients.

Dr. Merrill currently services as the associate program director of the Division of Urology residency program. 


Accepted Insurances

We accept a variety of health insurance plans and will submit claims on your behalf. Certain coverage restrictions may apply based on your individual benefit package.

View Accepted Insurances

Professional Education


Medical School, University of North Carolina School of Medicine (Chapel Hill) - 2007


Fellowship, Urologic Oncology Surg Mayo Clinic - Rochester, MN - 2015


Residency, Urology Duke University Hospital - 2013


Internship, General Surgery Duke University Hospital - 2008

Research Interests

  • Individualizing urologic cancer surveillance following surgery to enhance patient satisfaction and promote value-based care.
  • Optimizing urologic cancer care pathways following surgery to reduce complications and hospital readmissions.